Equities analysts expect LHC Group, Inc. (NASDAQ:LHCG) to announce $0.60 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for LHC Group’s earnings. The highest EPS estimate is $0.61 and the lowest is $0.59. LHC Group reported earnings per share of $0.48 in the same quarter last year, which suggests a positive year-over-year growth rate of 25%. The company is scheduled to report its next earnings results on Wednesday, May 2nd.
According to Zacks, analysts expect that LHC Group will report full year earnings of $3.50 per share for the current year, with EPS estimates ranging from $3.48 to $3.52. For the next year, analysts forecast that the business will post earnings of $4.07 per share, with EPS estimates ranging from $3.89 to $4.20. Zacks’ EPS averages are an average based on a survey of analysts that follow LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, February 28th. The health services provider reported $0.62 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.62. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The firm had revenue of $292.40 million during the quarter, compared to analyst estimates of $280.82 million. During the same period last year, the company earned $0.58 earnings per share. The business’s revenue for the quarter was up 24.2% on a year-over-year basis.
In related news, COO Donald Dwayne Stelly sold 14,216 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $64.00, for a total value of $909,824.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 14.80% of the company’s stock.
Several hedge funds have recently modified their holdings of LHCG. Renaissance Technologies LLC raised its position in shares of LHC Group by 1,862.8% in the fourth quarter. Renaissance Technologies LLC now owns 184,500 shares of the health services provider’s stock worth $11,301,000 after buying an additional 175,100 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its position in LHC Group by 558.3% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 200,000 shares of the health services provider’s stock valued at $12,250,000 after purchasing an additional 169,620 shares in the last quarter. Deutsche Bank AG raised its position in LHC Group by 371.5% during the fourth quarter. Deutsche Bank AG now owns 148,880 shares of the health services provider’s stock valued at $9,117,000 after purchasing an additional 117,301 shares in the last quarter. Allianz Asset Management GmbH raised its position in LHC Group by 148.2% during the fourth quarter. Allianz Asset Management GmbH now owns 125,263 shares of the health services provider’s stock valued at $7,673,000 after purchasing an additional 74,793 shares in the last quarter. Finally, Dalton Greiner Hartman Maher & Co. raised its position in LHC Group by 24.8% during the fourth quarter. Dalton Greiner Hartman Maher & Co. now owns 304,858 shares of the health services provider’s stock valued at $18,673,000 after purchasing an additional 60,563 shares in the last quarter. Institutional investors own 89.91% of the company’s stock.
LHC Group stock opened at $74.31 on Tuesday. LHC Group has a one year low of $51.61 and a one year high of $76.14. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.97 and a quick ratio of 1.97. The firm has a market capitalization of $1,342.13, a PE ratio of 30.97, a P/E/G ratio of 1.18 and a beta of 0.70.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.